Package 65145-114-05

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 65145-114-05
Digits Only 6514511405
Product NDC 65145-114
Description

5 VIAL, SINGLE-DOSE in 1 CARTON (65145-114-05) / 4 mL in 1 VIAL, SINGLE-DOSE (65145-114-01)

Marketing

Marketing Status
Marketed Since 2025-01-16
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "fb2643f1-42d0-410c-a4ab-b0a8ce457cfe", "openfda": {"upc": ["0365145113016", "0365145113252", "0365145114013"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["e18cc04c-a808-4d92-9b66-762cd787abc5"], "manufacturer_name": ["Caplin Steriles Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (65145-114-05)  / 4 mL in 1 VIAL, SINGLE-DOSE (65145-114-01)", "package_ndc": "65145-114-05", "marketing_start_date": "20250116"}], "brand_name": "Verapamil Hydrochloride", "product_id": "65145-114_fb2643f1-42d0-410c-a4ab-b0a8ce457cfe", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "65145-114", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Caplin Steriles Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA213232", "marketing_category": "ANDA", "marketing_start_date": "20250116", "listing_expiration_date": "20261231"}